Next Article in Journal
Evaluation of Patient-Assessed Quality of Life Questionnaires Following Operative Treatment of Pelvic Fractures
Previous Article in Journal
Effects of Bonded Rapid Palatal Expander on Vertical Dimension: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
Pilot Study of AI-Assisted ANA Immunofluorescence Reading—Comparison with Classical Visual Interpretation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Evaluating the Divide Between Patients’ and Physicians’ Perceptions of Adult-Onset Still’s Disease Cases: Insights from the PRO-AOSD Survey

1
Department of Internal Medicine V, Division of Rheumatology, University Hospital Heidelberg, 69120 Heidelberg, Germany
2
Center for Rare Diseases Heidelberg (ZSEHD), University Hospital Heidelberg, 69120 Heidelberg, Germany
3
Rheumatology Research, Faculty of Medicine, Ruhr-Universität Bochum, 44780 Bochum, Germany
4
Internal Medicine and Rheumatology, Rheumazentrum Ruhrgebiet, 44649 Herne, Germany
5
Department of Internal Medicine 3—Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany
6
Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, 91054 Erlangen, Germany
7
Center for Rare Diseases Erlangen (ZSEER), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, 91054 Erlangen, Germany
8
Novartis Pharma AG, CH-4056 Basel, Switzerland
9
Department of Rheumatology and Clinical Immunology, Helios Fachklinik Vogelsang-Gommern Klinik für Rheumatologie, 39245 Gommern, Germany
10
Experimental Rheumatology, Otto-von-Guericke Universität Magdeburg, 39106 Magdeburg, Germany
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(19), 7034; https://doi.org/10.3390/jcm14197034 (registering DOI)
Submission received: 28 August 2025 / Revised: 26 September 2025 / Accepted: 30 September 2025 / Published: 4 October 2025

Abstract

Background/Objectives: This study aims to report and compare data from the PRO-AOSD (patient-reported outcomes adult-onset Still’s disease) survey in patients with AOSD from the perspective of patients and their treating physicians. Methods: PRO-AOSD comprised blinded patient and physician surveys. The surveys were designed to assess perceived symptoms and physical impairment. Outcomes reported here include patient demographics; physicians’ assessment of the patient’s health state; physician-reported laboratory findings; pain; disease activity; symptoms; physicians’ treatment goals; and the impact of lifestyle factors on disease improvement. Results: Adult patients with AOSD were recruited from 19 centers in Germany. A total of 124 patients were included, with 74 (59.7%) females; the mean age was 45.5 years. The mean time from first symptom to diagnosis was 2 years, and the mean time was 7 years from diagnosis to survey completion (N = 123). Of 107 patients, most (81.3%) had inactive disease defined by CRP levels. At the time of the survey, around two-thirds of patients were receiving biologic therapy, with 84.1% (69/82) reporting an improvement in symptoms. Many patients had previously received antibiotics (47.6% [n = 58] and 30.4% [n = 37], per patient and physician reports, respectively). Persistent symptoms were reported more frequently by patients than by physicians, including back pain (39.5%), fatigue and weakness (38.7%), and joint inflammation (27.4%). Physicians classified 35.5% of patients as symptom-free. Patients reported exercise as having a positive impact on symptoms (52.4%), while stress (74.2%) and sleep deprivation (62.9%) were reported to worsen symptoms. Targeting systemic manifestations, such as the absence of fever (58.1%, n = 72), was considered the most important treatment goal by physicians. Conclusions: Data from PRO-AOSD highlight distinct differences between patients’ and physicians’ interpretations of the same cases of AOSD. Prior presentation: These data were presented at the German Congress of Rheumatology (DGRh; 30 August–2 September 2023; Leipzig, Germany).
Keywords: rheumatology; Still’s disease; Adult-Onset; inflammation; patient-reported outcome measures rheumatology; Still’s disease; Adult-Onset; inflammation; patient-reported outcome measures

Share and Cite

MDPI and ACS Style

Blank, N.; Andreica, I.; Rech, J.; Sözen, Z.; Feist, E. Evaluating the Divide Between Patients’ and Physicians’ Perceptions of Adult-Onset Still’s Disease Cases: Insights from the PRO-AOSD Survey. J. Clin. Med. 2025, 14, 7034. https://doi.org/10.3390/jcm14197034

AMA Style

Blank N, Andreica I, Rech J, Sözen Z, Feist E. Evaluating the Divide Between Patients’ and Physicians’ Perceptions of Adult-Onset Still’s Disease Cases: Insights from the PRO-AOSD Survey. Journal of Clinical Medicine. 2025; 14(19):7034. https://doi.org/10.3390/jcm14197034

Chicago/Turabian Style

Blank, Norbert, Ioana Andreica, Jürgen Rech, Zekayi Sözen, and Eugen Feist. 2025. "Evaluating the Divide Between Patients’ and Physicians’ Perceptions of Adult-Onset Still’s Disease Cases: Insights from the PRO-AOSD Survey" Journal of Clinical Medicine 14, no. 19: 7034. https://doi.org/10.3390/jcm14197034

APA Style

Blank, N., Andreica, I., Rech, J., Sözen, Z., & Feist, E. (2025). Evaluating the Divide Between Patients’ and Physicians’ Perceptions of Adult-Onset Still’s Disease Cases: Insights from the PRO-AOSD Survey. Journal of Clinical Medicine, 14(19), 7034. https://doi.org/10.3390/jcm14197034

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop